Drugs for the Treatment of Hyperlipidemia
Hyperlipidemia is a major risk factor for the development of cardiovascular disease. Considerable evidence suggests that drugs with the ability to lower low density lipoprotein-cholesterol also lower cardiovascular deaths.
Stone, William L., Chin, T K.
core
Relationship between hyperlipidemia and lumbar disc degeneration in patients with low back pain: an observational retrospective study. [PDF]
Wang S +5 more
europepmc +1 more source
Based on a Single Case, Cardiopulmonary Training Cannot Be Recommended as Therapy for Hemiparesis in MELAS With Ischemic Stroke. [PDF]
Mehri S, Finsterer J.
europepmc +1 more source
Treatment of Cardiometabolic Risk Factors Among U.S. Adults With Cardiovascular-Kidney-Metabolic Syndrome. [PDF]
Gong J +5 more
europepmc +1 more source
Zexie decoction alleviates hyperlipidemia through modulation of the PPAR signaling pathway and lysophospholipid metabolism. [PDF]
Li S, Wen ZQ, Yan P.
europepmc +1 more source
Lifestyle and metabolic determinants of early- and late-onset colorectal cancer: insights from a tertiary medical center in Alabama. [PDF]
Patel PG +4 more
europepmc +1 more source
Diagnostic performance of the vertebral bone quality score for osteoporosis is minimally influenced by lipid parameters in lumbar fusion patients: a retrospective study. [PDF]
Hu F +7 more
europepmc +1 more source
Hyperlipidémie combinée familiale [Familial combined hyperlipidemia]
Familial combined hyperlipidemia is a common inherited disorder characterized by a hepatic overproduction of apo B particles and an elevated risk for the development of atherosclerosis. LDL particles are smaller and denser and are more prone to oxidation.
Martin, G +3 more
core
Familial Hypercholesterolemia Combined With Sitosterolemia. [PDF]
Sun J, Han X, He Y, Jiang Y.
europepmc +1 more source
Exploring the association between gastroesophageal reflux disease and hyperlipidemia through bioinformatics and Mendelian randomization. [PDF]
Sun Y +5 more
europepmc +1 more source

